Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Hypothalamic-Pituitary Axis

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The effect of timing of physical exercise on glycemia: a systematic review and meta-analysis of human intervention studies.

Journal of diabetes and metabolic disorders·2026

Same author

Author Correction: Regulatory T cells in the mouse hypothalamus control immune activation and ameliorate metabolic impairments in high-calorie environments.

Nature communications·2026

Same author

Publisher Correction: GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026

Same author

GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026

Same author

Targeted PPARδ activation reprograms microglial immunometabolism and improves insulin sensitivity in HFD-fed rats.

Journal of lipid research·2026

Same author

Hypothalamic astrocytes: connecting brain and periphery in metabolic control.

Reviews in endocrine & metabolic disorders·2025

Search research articles

Related Experiment Video

Updated: Feb 8, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Hypothalamic astrocytes in obesity.

Cristina García-Cáceres¹, Chun-Xia Yi, Matthias H Tschöp

¹Institute for Diabetes and Obesity, Helmholtz Centre Munich, 85748 Garching, Munich, Germany.

Endocrinology and Metabolism Clinics of North America

|February 9, 2013

Summary

This summary is machine-generated.

Hypothalamic inflammation, driven by astrocytes, precedes obesity and weight gain. Targeting these brain cells offers a novel approach for obesity treatment.

More Related Videos

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model

Published on: April 16, 2014

Related Experiment Videos

Last Updated: Feb 8, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model

Published on: April 16, 2014

Area of Science:

Neuroendocrinology
Neuroinflammation
Metabolic disease research

Background:

Obesity is linked to chronic, low-grade inflammation, particularly in the hypothalamus.
Hypothalamic inflammation is an early event in obesity development, occurring before significant weight gain.
Microglia and astrocytes within the hypothalamus produce cytokines, contributing to inflammatory responses.

Purpose of the Study:

To review evidence on the role of hypothalamic astrocytes in obesity.
To propose a new neuroendocrine research approach for understanding obesity pathogenesis.
To identify novel therapeutic strategies for obesity targeting hypothalamic astrocytes.

Main Methods:

Review of existing scientific literature on hypothalamic inflammation and obesity.
Analysis of the specific role of astrocytes in nutrient excess and inflammatory signaling.
Synthesis of evidence linking astrocyte function to obesity development.

Main Results:

Astrocytes are significantly affected by nutrient excess in the hypothalamus.
Astrocytes play a crucial role in promoting hypothalamic inflammation associated with obesity.
Evidence supports astrocytes as key contributors to the inflammatory processes driving obesity.

Conclusions:

Hypothalamic astrocytes are central players in the inflammatory cascade of obesity.
Targeting astrocyte-mediated inflammation presents a promising avenue for novel obesity treatments.
Further neuroendocrine research focusing on astrocytes is needed to develop effective obesity therapies.